Ionis Pharmaceuticals (IONS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ionis Pharmaceuticals (IONS)

IONS 71.29

+2.1%

1:35 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tommysdad who wrote (2219)	8/24/1998 4:18:00 PM
From: jopawa	Read Replies (1) of 4676

Anybody have technical info on the impact of CNTO's Crohn's drug, biz.yahoo.com, and how it relates to ISIP's efforts? Obviously first to market is better, but are they attacking the same thing, or different stages of the disease? Certainly good news for CNTO. ISIP stock price seems to be discounting everything bad happening, but who is to say it can't go lower. Such is the nature of biotech investing in particular, and out of favor stocks in general. John

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next